BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 9479348)

  • 1. PAPNET testing for HSILs. The few cell/small cell challenge.
    Solomon HM; Frist S
    Acta Cytol; 1998; 42(1):253-9. PubMed ID: 9479348
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neural-network-assisted analysis and microscopic rescreening in presumed negative cervical cytologic smears. A comparison.
    Mango LJ; Valente PT
    Acta Cytol; 1998; 42(1):227-32. PubMed ID: 9479345
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Negative cervical smears before CIN 3/carcinoma. Reevaluation with the PAPNET Testing System.
    Doornewaard H; van de Seijp H; Woudt JM; van der Graaf Y; van den Tweel JG
    Acta Cytol; 1997; 41(1):74-8. PubMed ID: 9022729
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Consistency of a double PAPNET scan of cervical smears.
    Jenny J; Isenegger I; Boon ME; Husain OA
    Acta Cytol; 1997; 41(1):82-7. PubMed ID: 9022731
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased detection of epithelial cell abnormalities by liquid-based gynecologic cytology preparations. A review of accumulated data.
    Austin RM; Ramzy I
    Acta Cytol; 1998; 42(1):178-84. PubMed ID: 9479337
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of unsuspected abnormalities by PAPNET-assisted review.
    Mitchell H; Medley G
    Acta Cytol; 1998; 42(1):260-4. PubMed ID: 9479349
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A feasibility study of the AutoPap system location-guided screening.
    Lee JS; Kuan L; Oh S; Patten FW; Wilbur DC
    Acta Cytol; 1998; 42(1):221-6. PubMed ID: 9479344
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Observer variation in cytologic grading for cervical dysplasia of Papanicolaou smears with the PAPNET testing system.
    Doornewaard H; van der Schouw YT; van der Graaf Y; Bos AB; van den Tweel JG
    Cancer; 1999 Aug; 87(4):178-83. PubMed ID: 10455204
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the PAPNET system in a general pathology service.
    Farnsworth A; Chambers FM; Goldschmidt CS
    Med J Aust; 1996 Oct; 165(8):429-31. PubMed ID: 8913244
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [An interlaboratory study of the use of PapNet in the quality control of cervico-vaginal cytology].
    Cosentino A; Ghidoni D; Salemi M; Folicaldi S; Amadori A; Zani J; Grasso G; Bondi A
    Pathologica; 1999 Apr; 91(2):101-6. PubMed ID: 10484869
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The AutoPap system for primary screening in cervical cytology. Comparing the results of a prospective, intended-use study with routine manual practice.
    Wilbur DC; Prey MU; Miller WM; Pawlick GF; Colgan TJ
    Acta Cytol; 1998; 42(1):214-20. PubMed ID: 9479343
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rescreen effect in conventional and PAPNET screening: observed in a study using material enriched with positive smears.
    van Ballegooijen M; Beck S; Boon ME; Boer R; Habbema JD
    Acta Cytol; 1998; 42(5):1133-8. PubMed ID: 9755670
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the PAPNET cytologic screening system for quality control of cervical smears.
    Koss LG; Lin E; Schreiber K; Elgert P; Mango L
    Am J Clin Pathol; 1994 Feb; 101(2):220-9. PubMed ID: 8116579
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Simulation of primary cervical cancer screening by the PAPNET system in an unscreened, high-risk community.
    Michelow PM; Hlongwane NF; Leiman G
    Acta Cytol; 1997; 41(1):88-92. PubMed ID: 9022732
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical validation of interactive cytologic screening. Automating the search, not the interpretation.
    Mango LJ
    Acta Cytol; 1997; 41(1):93-7. PubMed ID: 9022733
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the SurePath liquid-based Papanicolaou smear with the conventional Papanicolaou smear in a multisite direct-to-vial study.
    Fremont-Smith M; Marino J; Griffin B; Spencer L; Bolick D
    Cancer; 2004 Oct; 102(5):269-79. PubMed ID: 15386329
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PAPNET Testing System. Technical update.
    Denaro TJ; Herriman JM; Shapira O
    Acta Cytol; 1997; 41(1):65-73. PubMed ID: 9022728
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Costs and outcomes of PAPNET secondary screening technology for cervical cytologic evaluation. A community hospital's experience.
    Brotzman GL; Kretzchmar S; Ferguson D; Gottlieb M; Stowe C
    Arch Fam Med; 1999; 8(1):52-5. PubMed ID: 9932072
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The ThinPrep Pap test. A review of clinical studies.
    Linder J; Zahniser D
    Acta Cytol; 1997; 41(1):30-8. PubMed ID: 9022723
    [TBL] [Abstract][Full Text] [Related]  

  • 20. AutoCyte SCREEN interactive automated primary cytology screening system. A preliminary evaluation.
    Takahashi M; Kimura M; Akagi A; Naitoh M
    Acta Cytol; 1998; 42(1):185-8. PubMed ID: 9479338
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.